These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 33809233)
1. Virulence and Antifungal Susceptibility of Aneke CI; Rhimi W; Hubka V; Otranto D; Cafarchia C Antibiotics (Basel); 2021 Mar; 10(3):. PubMed ID: 33809233 [TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of E-test and CLSI methods for Itraconazole, Fluconazole and Ketoconazole susceptibilities of Microsporum canis strains. Aneke CI; Rhimi W; Otranto D; Cafarchia C Mycopathologia; 2020 Jun; 185(3):495-502. PubMed ID: 32468154 [TBL] [Abstract][Full Text] [Related]
3. Virulence factors of Malassezia strains isolated from pityriasis versicolor patients and healthy individuals. Chebil W; Rhimi W; Haouas N; Romano V; Belgacem S; Belhadj Ali H; Babba H; Cafarchia C Med Mycol; 2022 Aug; 60(8):. PubMed ID: 35913746 [TBL] [Abstract][Full Text] [Related]
4. Systemic antifungal therapy for tinea capitis in children. Chen X; Jiang X; Yang M; González U; Lin X; Hua X; Xue S; Zhang M; Bennett C Cochrane Database Syst Rev; 2016 May; 2016(5):CD004685. PubMed ID: 27169520 [TBL] [Abstract][Full Text] [Related]
5. The best type of inoculum for testing the antifungal drug susceptibility of Microsporum canis: In vivo and in vitro results. Aneke CI; Rhimi W; Pellicoro C; Cantacessi C; Otranto D; Cafarchia C Mycoses; 2020 Jul; 63(7):711-716. PubMed ID: 32299129 [TBL] [Abstract][Full Text] [Related]
6. Comparison of virulence factors and susceptibility profiles of Malassezia furfur from pityriasis versicolor patients and bloodstream infections of preterm infants. Rhimi W; Chebil W; Ugochukwu ICI; Babba H; Otranto D; Cafarchia C Med Mycol; 2022 Dec; 61(1):. PubMed ID: 36626926 [TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility testing of dermatophytes isolated in Goiania, Brazil, against five antifungal agents by broth microdilution method. Araújo CR; Miranda KC; Fernandes Ode F; Soares AJ; Silva Mdo R Rev Inst Med Trop Sao Paulo; 2009; 51(1):9-12. PubMed ID: 19229384 [TBL] [Abstract][Full Text] [Related]
9. Synergistic Effects of Efflux Pump Modulators on the Azole Antifungal Susceptibility of Microsporum canis. Aneke CI; Rhimi W; Otranto D; Cafarchia C Mycopathologia; 2020 Apr; 185(2):279-288. PubMed ID: 31894500 [TBL] [Abstract][Full Text] [Related]
10. In vitro evaluation of antifungal susceptibility and keratinase, elastase, lipase and DNase activities of different dermatophyte species isolated from clinical specimens in Iran. Sharifzadeh A; Shokri H; Khosravi AR Mycoses; 2016 Nov; 59(11):710-719. PubMed ID: 27291045 [TBL] [Abstract][Full Text] [Related]
11. [In vitro activity of voriconazole and three other antifungal agents against dermatophytes]. Serrano-Martino Mdel C; Chávez-Caballero M; Valverde-Conde A; Claro RM; Pemán J; Martín-Mazuelos E Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):484-7. PubMed ID: 14572380 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of microdilution and disk diffusion methods for antifungal susceptibility testing of dermatophytes. Singh J; Zaman M; Gupta AK Med Mycol; 2007 Nov; 45(7):595-602. PubMed ID: 17885958 [TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of seven antifungal agents against dermatophytes isolated in İstanbul. Altınbaş R; Özakkaş F; Barış A; Turan D; Şen S Turk J Med Sci; 2018 Jun; 48(3):615-619. PubMed ID: 29916221 [TBL] [Abstract][Full Text] [Related]
15. In vitro virulotyping, antifungal susceptibility testing and DNA fingerprinting of Microsporum canis strains of canine and feline origin. Bagra JK; Nair SS; Athira V; Suman Kumar M; Kumar M; Thomas P; Kumar B; Chaturvedi VK; Dandapat P; Abhishek Comp Immunol Microbiol Infect Dis; 2024 Jan; 104():102100. PubMed ID: 38043450 [TBL] [Abstract][Full Text] [Related]
16. Comparative Analysis of Putative Virulence-Associated Factors of Microsporum canis Isolates from Human and Animal Patients. Ramos MLM; Coelho RA; Brito-Santos F; Guimarães D; Premazzi M; Zancopé-Oliveira RM; Pereira SA; Gremião IDF; Orofino-Costa R; Figueiredo-Carvalho MHG; Almeida-Paes R Mycopathologia; 2020 Aug; 185(4):665-673. PubMed ID: 32643011 [TBL] [Abstract][Full Text] [Related]
17. Nannizzia incurvata in Hue city - Viet Nam: Molecular identification and antifungal susceptibility testing. Ngo TMC; Ton Nu PA; Le CC; Vo MT; Ha TNT; Do TBT; Nguyen PV; Tran Thi G; Santona A J Mycol Med; 2022 Aug; 32(3):101291. PubMed ID: 35550973 [TBL] [Abstract][Full Text] [Related]
18. Zhou YB; Xiao YY; Chao JJ; Ma L Front Med (Lausanne); 2021; 8():783086. PubMed ID: 34901093 [TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes. Tamura T; Asahara M; Yamamoto M; Yamaura M; Matsumura M; Goto K; Rezaei-Matehkolaei A; Mirhendi H; Makimura M; Makimura K Microbiol Immunol; 2014 Jan; 58(1):1-8. PubMed ID: 24215461 [TBL] [Abstract][Full Text] [Related]